LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

LLY

1,128.97

-0.68%↓

JNJ

235.88

-1.96%↓

ABBV

221

-2.87%↓

UNH

410.35

+0.51%↑

MRK

114.88

-3.62%↓

Search

Check Cap Ltd

Suletud

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad

By Trading Economics

Sissetulek

-9.4K

EBITDA

-1.3M

Turustatistika

By TradingEconomics

Turukapital

9.4M

Eelmine avamishind

0

Eelmine sulgemishind

0

Check Cap Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Ettevõttest Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
help-icon Live chat